Mishima K, Obika S, Shimojo M
Mol Ther Nucleic Acids. 2024; 35(3):102250.
PMID: 39377066
PMC: 11456559.
DOI: 10.1016/j.omtn.2024.102250.
Jin L, Liu Y, Wu Y, Huang Y, Zhang D
Biomolecules. 2023; 13(10).
PMID: 37892159
PMC: 10605157.
DOI: 10.3390/biom13101477.
Labrecque M, Brown L, Coleman I, Lakely B, Brady N, Lee J
Cancer Res. 2021; 81(18):4736-4750.
PMID: 34312180
PMC: 8448969.
DOI: 10.1158/0008-5472.CAN-21-0307.
McGann J, Spinner M, Garg S, Mullendorff K, Woltjer R, Mandel G
J Neurosci. 2021; 41(31):6582-6595.
PMID: 34210779
PMC: 8336698.
DOI: 10.1523/JNEUROSCI.2059-20.2021.
Ho N, Rahane C, Pramanik S, Kim P, Kutzner A, Heese K
Cancers (Basel). 2021; 13(5).
PMID: 33804473
PMC: 7957592.
DOI: 10.3390/cancers13051025.
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates.
Belluti S, Rigillo G, Imbriano C
Cells. 2020; 9(3).
PMID: 32244895
PMC: 7140685.
DOI: 10.3390/cells9030760.
Loss of RE-1 silencing transcription factor accelerates exocrine damage from pancreatic injury.
Bray J, Elgamal O, Jiang J, Wright L, Sutaria D, Badawi M
Cell Death Dis. 2020; 11(2):138.
PMID: 32080178
PMC: 7033132.
DOI: 10.1038/s41419-020-2269-7.
News about the Role of the Transcription Factor REST in Neurons: From Physiology to Pathology.
Garcia-Manteiga J, DAlessandro R, Meldolesi J
Int J Mol Sci. 2020; 21(1).
PMID: 31905747
PMC: 6982158.
DOI: 10.3390/ijms21010235.
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.
Labrecque M, Coleman I, Brown L, True L, Kollath L, Lakely B
J Clin Invest. 2019; 129(10):4492-4505.
PMID: 31361600
PMC: 6763249.
DOI: 10.1172/JCI128212.
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.
Balanis N, Sheu K, Esedebe F, Patel S, Smith B, Park J
Cancer Cell. 2019; 36(1):17-34.e7.
PMID: 31287989
PMC: 6703903.
DOI: 10.1016/j.ccell.2019.06.005.
NRSF and Its Epigenetic Effectors: New Treatments for Neurological Disease.
Thompson R, Chan C
Brain Sci. 2018; 8(12).
PMID: 30572571
PMC: 6316267.
DOI: 10.3390/brainsci8120226.
Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease.
Chen G, Ma Q, Goswami D, Shang J, Miller G
J Cell Mol Med. 2017; 21(11):2974-2984.
PMID: 28524599
PMC: 5661251.
DOI: 10.1111/jcmm.13209.